181 related articles for article (PubMed ID: 35959629)
1. Drug-microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL.
Bruch PM; Giles HA; Kolb C; Herbst SA; Becirovic T; Roider T; Lu J; Scheinost S; Wagner L; Huellein J; Berest I; Kriegsmann M; Kriegsmann K; Zgorzelski C; Dreger P; Zaugg JB; Müller-Tidow C; Zenz T; Huber W; Dietrich S
Mol Syst Biol; 2022 Aug; 18(8):e10855. PubMed ID: 35959629
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
[TBL] [Abstract][Full Text] [Related]
3. NF-κB activation in chronic lymphocytic leukemia: A point of convergence of external triggers and intrinsic lesions.
Mansouri L; Papakonstantinou N; Ntoufa S; Stamatopoulos K; Rosenquist R
Semin Cancer Biol; 2016 Aug; 39():40-8. PubMed ID: 27491692
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
[TBL] [Abstract][Full Text] [Related]
5. B-cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalities.
Falisi E; Novella E; Visco C; Guercini N; Maura F; Giaretta I; Pomponi F; Nichele I; Finotto S; Montaldi A; Neri A; Rodeghiero F
Hematol Oncol; 2014 Mar; 32(1):22-30. PubMed ID: 23861036
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 receptor-associated kinase 4 inhibitor interrupts toll-like receptor signalling and sensitizes chronic lymphocytic leukaemia cells to apoptosis.
Delvecchio VS; Sana I; Mantione ME; Vilia MG; Ranghetti P; Rovida A; Angelillo P; Scarfò L; Ghia P; Muzio M
Br J Haematol; 2020 May; 189(3):475-488. PubMed ID: 32057093
[TBL] [Abstract][Full Text] [Related]
7. Complex chromosomal aberrations in chronic lymphocytic leukemia are associated with cellular drug and irradiation resistance.
Koski T; Karhu R; Visakorpi T; Vilpo L; Knuutila S; Vilpo J
Eur J Haematol; 2000 Jul; 65(1):32-9. PubMed ID: 10914937
[TBL] [Abstract][Full Text] [Related]
8. Pro-apoptotic TP53 homolog TAp63 is repressed via epigenetic silencing and B-cell receptor signalling in chronic lymphocytic leukaemia.
Humphries LA; Godbersen JC; Danilova OV; Kaur P; Christensen BC; Danilov AV
Br J Haematol; 2013 Dec; 163(5):590-602. PubMed ID: 24117128
[TBL] [Abstract][Full Text] [Related]
9. In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: a cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients.
Geisler CH; Philip P; Christensen BE; Hou-Jensen K; Pedersen NT; Jensen OM; Thorling K; Andersen E; Birgens HS; Drivsholm A; Ellegaard J; Larsen JK; Plesner T; Brown P; Andersen PK; Hansen MM
Leuk Res; 1997; 21(11-12):1011-23. PubMed ID: 9444933
[TBL] [Abstract][Full Text] [Related]
10. Microenvironmental interactions in chronic lymphocytic leukemia: the master role of CD49d.
Dal Bo M; Tissino E; Benedetti D; Caldana C; Bomben R; Del Poeta G; Gaidano G; Rossi FM; Zucchetto A; Gattei V
Semin Hematol; 2014 Jul; 51(3):168-76. PubMed ID: 25048781
[TBL] [Abstract][Full Text] [Related]
11. From pathogenesis to treatment of chronic lymphocytic leukaemia.
Zenz T; Mertens D; Küppers R; Döhner H; Stilgenbauer S
Nat Rev Cancer; 2010 Jan; 10(1):37-50. PubMed ID: 19956173
[TBL] [Abstract][Full Text] [Related]
12. Trisomy 12 and elevated GLI1 and PTCH1 transcript levels are biomarkers for Hedgehog-inhibitor responsiveness in CLL.
Decker S; Zirlik K; Djebatchie L; Hartmann D; Ihorst G; Schmitt-Graeff A; Herchenbach D; Jumaa H; Warmuth M; Veelken H; Dierks C
Blood; 2012 Jan; 119(4):997-1007. PubMed ID: 22130798
[TBL] [Abstract][Full Text] [Related]
13. Concurrent rearrangements of BCL2, BCL3, and BCL11A genes in atypical chronic lymphocytic leukemia.
Podgornik H; Pretnar J; Skopec B; Andoljšek D; Černelč P
Hematology; 2014 Jan; 19(1):45-8. PubMed ID: 23432949
[TBL] [Abstract][Full Text] [Related]
14. The protein landscape of chronic lymphocytic leukemia.
Meier-Abt F; Lu J; Cannizzaro E; Pohly MF; Kummer S; Pfammatter S; Kunz L; Collins BC; Nadeu F; Lee KS; Xue P; Gwerder M; Roiss M; Hüllein J; Scheinost S; Dietrich S; Campo E; Huber W; Aebersold R; Zenz T
Blood; 2021 Dec; 138(24):2514-2525. PubMed ID: 34189564
[TBL] [Abstract][Full Text] [Related]
15. Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.
Mittal AK; Chaturvedi NK; Rai KJ; Gilling-Cutucache CE; Nordgren TM; Moragues M; Lu R; Opavsky R; Bociek GR; Weisenburger DD; Iqbal J; Joshi SS
Mol Med; 2014 Jul; 20(1):290-301. PubMed ID: 24800836
[TBL] [Abstract][Full Text] [Related]
16. Cell surface expression of CD25, CD54, and CD95 on B- and T-cells in chronic lymphocytic leukaemia in relation to trisomy 12, atypical morphology and clinical course.
Hjalmar V; Hast R; Kimby E
Eur J Haematol; 2002 Mar; 68(3):127-34. PubMed ID: 12068792
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of CD154/IL4 proliferation by the T follicular helper (Tfh) cytokine, IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia.
Ahearne MJ; Willimott S; Piñon L; Kennedy DB; Miall F; Dyer MJ; Wagner SD
Br J Haematol; 2013 Aug; 162(3):360-70. PubMed ID: 23710828
[TBL] [Abstract][Full Text] [Related]
19. Gene expression signature of chronic lymphocytic leukaemia with Trisomy 12.
Porpaczy E; Bilban M; Heinze G; Gruber M; Vanura K; Schwarzinger I; Stilgenbauer S; Streubel B; Fonatsch C; Jaeger U
Eur J Clin Invest; 2009 Jul; 39(7):568-75. PubMed ID: 19453646
[TBL] [Abstract][Full Text] [Related]
20. MEK1/2 inhibition by binimetinib is effective as a single agent and potentiates the actions of Venetoclax and ABT-737 under conditions that mimic the chronic lymphocytic leukaemia (CLL) tumour microenvironment.
Crassini K; Shen Y; Stevenson WS; Christopherson R; Ward C; Mulligan SP; Best OG
Br J Haematol; 2018 Aug; 182(3):360-372. PubMed ID: 29767411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
